PDCD1 and non-small cell lung carcinoma: Hence, while the relationship between IL-1β and PD-1/PD-L1 pathways in the TME of NSCLC is significant, further research is needed to elucidate the exact mechanisms and improve outcomes with IL-1β and PD-1/PD-L1 inhibitors.